Email alerts are important as you can keep track of your competitors and targets of interest, and prevent missing crucial information on competitive threats such as new organizations entering a target market. As manually checking updates and information can be very time-consuming, email alerts will allow you to monitor at a target, company, and drug level.
Target level: change in drug status, new indications, new organizations, and any new documents
The development of drugs often starts with a target, and research and development personnel at pharmaceutical companies need to keep up with target-related information trends. New active drugs under development, inactive drugs, new active indications, new active organizations, and related documents such as patents, news, clinical trials, and literature alerts will be pushed to you via the target level email reminder.
Company level: change in drug status, new targets, and any new documents
The project establishment department of a pharmaceutical company is concerned about another company's research and development trends, such as pipeline updates. You can stay up-to-date on active drugs, inactive drugs, and new active drugs by using this email alert.
Drug level: any new documents
As well as providing R&D status updates and clinical trial updates, this alert provides drug-related literature, news, and patent updates.
